Biogen, one of the largest biotechs in the world, said the decision to stop the study was not based on safety concerns.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:
Biotech company shares plummet after ending potentially groundbreaking Alzheimer's drug trial
대한민국 뉴스 뉴스
The company said the decision to end the trial was not based on safety concerns